Systemic Immune Activation by SARS-CoV-2 mRNA Vaccines Sensitizes Tumors to Immune Checkpoint Blockade
Year: 2025
Type: article
Study design: Observational Study
Authors: A. Grippin, S.A. Copling, C. Marconi, N. Li, A. Kim, E. Young, J. Jafarnia, N. Nariman, H. Mendez-Gomez, W. Jiang, E. Sayour, S.H. Lin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414574306
